NCT05169762

Feminizing Treatment in Transgender Women and Non-binary Persons

Feminizing Treatment in Transgender Women and Non-binary Persons BODY IDENTITY CLINIC - ESTROGEN

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: Odense University Hospital · Academic / Other
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes regarding cardiovascular effects of hormone treatment.

Detailed description

Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes: Non-calcified and calcified plaque formation by contras coronary CT angiograms Heartfunction by ekko Cardiovaskular risk markers, f. eks. bp Markers of cardiovascular risk in blood and urine

Conditions

• Transgenderism

Interventions

Type	Name	Description
OTHER	standard treatment	starndard treatment for transgender women

Timeline

• Start date: 2022-02-01
• Primary completion: 2035-09-01
• Completion: 2035-09-01
• First posted: 2021-12-27
• Last updated: 2025-03-21

Locations

1 site across 1 country: Denmark